|
|
Volumn 2, Issue 5, 2005, Pages 242-243
|
|
How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?
|
|
Author keywords
Bone markers; Bone metastases; Lung cancer; Prostate cancer
|
|
Indexed keywords
ALKALINE PHOSPHATASE BONE ISOENZYME;
AMINO TERMINAL TELOPEPTIDE;
BISPHOSPHONIC ACID DERIVATIVE;
CREATININE;
ZOLEDRONIC ACID;
BONE METASTASIS;
BONE PAIN;
BONE SCINTISCANNING;
BONE TURNOVER;
CANCER MORTALITY;
CANCER PATIENT;
CANCER SURVIVAL;
CLINICAL TRIAL;
COHORT ANALYSIS;
CREATININE BLOOD LEVEL;
DATA ANALYSIS;
DIAGNOSTIC VALUE;
FRACTURE;
HUMAN;
HYPERCALCEMIA;
LUNG NON SMALL CELL CANCER;
OSSIFICATION;
OSTEOLYSIS;
PATHOPHYSIOLOGY;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
RELIABILITY;
SHORT SURVEY;
SOLID TUMOR;
STATISTICAL ANALYSIS;
AGED;
ALKALINE PHOSPHATASE;
BIOLOGICAL MARKERS;
BONE NEOPLASMS;
BONE RESORPTION;
COHORT STUDIES;
COLLAGEN;
COLLAGEN TYPE I;
FEMALE;
FRACTURES, BONE;
HUMANS;
MALE;
NEOPLASMS;
PAIN;
PEPTIDES;
PROGNOSIS;
QUALITY OF LIFE;
RISK ASSESSMENT;
SPINAL CORD COMPRESSION;
|
|
EID: 20444507610
PISSN: 17434254
EISSN: None
Source Type: Journal
DOI: 10.1038/ncponc0167 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (3)
|
